106 related articles for article (PubMed ID: 3214046)
1. [Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Navajas Gutiérrez A; Bezanilla Regato JL; Moya Calderón E; Piñán MA
An Esp Pediatr; 1988 Oct; 29 Suppl 34():91-3. PubMed ID: 3214046
[No Abstract] [Full Text] [Related]
2. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
[No Abstract] [Full Text] [Related]
3. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
Estlin EJ; Yule SM; Lowis SP
Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of acute refractory lymphoblastic leukemia in the adult with VM-26 and ARA-C].
Rafecas FJ; Sanz MA
Sangre (Barc); 1984; 29(6):1052-3. PubMed ID: 6598235
[No Abstract] [Full Text] [Related]
5. VM-26 and cytarabine combination chemotherapy in refractory or relapsed adult acute lymphoblastic leukemia.
Carella AM; Santini G; Martinengo M; Giordano D; Nati S; Congiu A; Risso M; Vimercati R; Cerri R; Rossi E
Haematologica; 1984; 69(6):747-51. PubMed ID: 6441752
[No Abstract] [Full Text] [Related]
6. Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
Rivera G; Avery T; Roberts DW
Eur J Cancer (1965); 1975 Sep; 11(9):639-47. PubMed ID: 1220978
[No Abstract] [Full Text] [Related]
7. Clinical trials of teniposide (VM-26) in childhood acute lymphocytic leukemia.
Rivera GK; Evans WE
Semin Oncol; 1992 Apr; 19(2 Suppl 6):51-8. PubMed ID: 1411639
[TBL] [Abstract][Full Text] [Related]
8. [High-risk acute lymphoblastic leukemia].
Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S
An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041
[No Abstract] [Full Text] [Related]
9. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
Ochocka M; Zelenay E
Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
[No Abstract] [Full Text] [Related]
10. A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine.
Dahl GV; Rivera G; Pui CH; Mirro J; Ochs J; Kalwinsky DK; Abromowitch M; Look AT; Murphy SB
Blood; 1985 Nov; 66(5):1110-4. PubMed ID: 3840395
[TBL] [Abstract][Full Text] [Related]
11. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
12. Etoposide and teniposide in the treatment of acute leukemia.
Björkholm M
Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
[TBL] [Abstract][Full Text] [Related]
13. [Allergic reactions to teniposide (VM-26) in children with neoplasms].
Wysocki M; Nowaczyk-Michalak A; Pilecki O
Wiad Lek; 1992 Feb; 45(3-4):91-3. PubMed ID: 1413803
[TBL] [Abstract][Full Text] [Related]
14. Teniposide for acute lymphoblastic leukemia.
Med Lett Drugs Ther; 1992 Nov; 34(883):105-6. PubMed ID: 1435505
[No Abstract] [Full Text] [Related]
15. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
[TBL] [Abstract][Full Text] [Related]
16. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
[TBL] [Abstract][Full Text] [Related]
17. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Kurrle E; Heimpel H; Koch P; Lipp T
Semin Oncol; 1987 Jun; 14(2 Suppl 1):92-7. PubMed ID: 3473688
[No Abstract] [Full Text] [Related]
18. Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.
Rosenstock JG; Donaldson MH
Cancer Treat Rep; 1976 Mar; 60(3):265-7. PubMed ID: 1063066
[No Abstract] [Full Text] [Related]
19. Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma.
Rivera G; Green A; Hayes A; Avery T; Pratt C
Cancer Treat Rep; 1977 Oct; 61(7):1243-8. PubMed ID: 589594
[TBL] [Abstract][Full Text] [Related]
20. [VP 16-213 in the treatment of acute leukemia in childhood].
Esumi N; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
